REFILE-UPDATE 1-Swiss biotech AC Immune taps U.S. IPO to fund Alzheimer's drugs
June 01, 2016 at 08:47 AM EDT
June 1 (Reuters) - Switzerland's AC Immune, which already has money in hand from Roche for its most advanced drug, is planning a share sale in the United States to raise up to $50 million for separate drug candidates targeting Alzheimer's disease.
